OBJECTIVES: GLUT-1 has been found to have an important role in the upregulation of various cellular pathways and implicated in neoplastic transformation correlating with biological behavior in malignancies. However, literature regarding the significance of GLUT-1 expression in pancreatic neoplasia has been limited and controversial. METHODS: Immunohistochemical expression of GLUT-1 was tested in a variety of pancreatic neoplasia including ductal adenocarcinomas (DAs), pancreatic intraepithelial neoplasms (PanINs), intraductal papillary mucinous neoplasms (IPMNs), and serous cystadenomas. RESULTS: There was a progressive increase in the expression of GLUT-1 from low- to higher-grade dysplastic lesions: All higher-grade PanINs/IPMNs (the ones with moderate/high-grade dysplasia) revealed noticeable GLUT-1 expression. Among the 94 DAs analyzed, there were minimal/moderate expression in 46 and significant expression in 24 DAs. However, all 4 clear-cell variants of DAs revealed significant GLUT-1 immunolabeling, as did areas of clear-cell change seen in other DAs. Moreover, all 12 serous cystadenomas expressed significant GLUT-1. GLUT-1 expression was also directly correlated with DA histological grade (P = 0.016) and tumor size (P = 0.03). CONCLUSIONS: GLUT-1 may give rise to the distinctive clear-cell appearance of these tumors by inducing the accumulation of glycogen in the cytoplasm. Additionally, because GLUT-1 expression was related to histological grade and tumor size of DA, further studies are warranted to investigate the association of GLUT-1 with prognosis and tumor progression.
OBJECTIVES:GLUT-1 has been found to have an important role in the upregulation of various cellular pathways and implicated in neoplastic transformation correlating with biological behavior in malignancies. However, literature regarding the significance of GLUT-1 expression in pancreatic neoplasia has been limited and controversial. METHODS: Immunohistochemical expression of GLUT-1 was tested in a variety of pancreatic neoplasia including ductal adenocarcinomas (DAs), pancreatic intraepithelial neoplasms (PanINs), intraductal papillary mucinous neoplasms (IPMNs), and serous cystadenomas. RESULTS: There was a progressive increase in the expression of GLUT-1 from low- to higher-grade dysplastic lesions: All higher-grade PanINs/IPMNs (the ones with moderate/high-grade dysplasia) revealed noticeable GLUT-1 expression. Among the 94 DAs analyzed, there were minimal/moderate expression in 46 and significant expression in 24 DAs. However, all 4 clear-cell variants of DAs revealed significant GLUT-1 immunolabeling, as did areas of clear-cell change seen in other DAs. Moreover, all 12 serous cystadenomas expressed significant GLUT-1. GLUT-1 expression was also directly correlated with DA histological grade (P = 0.016) and tumor size (P = 0.03). CONCLUSIONS:GLUT-1 may give rise to the distinctive clear-cell appearance of these tumors by inducing the accumulation of glycogen in the cytoplasm. Additionally, because GLUT-1 expression was related to histological grade and tumor size of DA, further studies are warranted to investigate the association of GLUT-1 with prognosis and tumor progression.
Authors: T Yamamoto; Y Seino; H Fukumoto; G Koh; H Yano; N Inagaki; Y Yamada; K Inoue; T Manabe; H Imura Journal: Biochem Biophys Res Commun Date: 1990-07-16 Impact factor: 3.575
Authors: T Higashi; N Tamaki; T Honda; T Torizuka; T Kimura; T Inokuma; G Ohshio; R Hosotani; M Imamura; J Konishi Journal: J Nucl Med Date: 1997-09 Impact factor: 10.057
Authors: T Kayano; C F Burant; H Fukumoto; G W Gould; Y S Fan; R L Eddy; M G Byers; T B Shows; S Seino; G I Bell Journal: J Biol Chem Date: 1990-08-05 Impact factor: 5.157
Authors: B Nakata; Y S Chung; S Nishimura; T Nishihara; Y Sakurai; T Sawada; T Okamura; J Kawabe; H Ochi; M Sowa Journal: Cancer Date: 1997-02-15 Impact factor: 6.860
Authors: Irem H Ozbudak; Konstantin Shilo; Fabio Tavora; Negar Rassaei; Wei-Sing Chu; Junya Fukuoka; Jin Jen; William D Travis; Teri J Franks Journal: Mod Pathol Date: 2009-02-20 Impact factor: 7.842
Authors: Maciej Serda; Matthew J Ware; Jared M Newton; Sanchit Sachdeva; Martyna Krzykawska-Serda; Lam Nguyen; Justin Law; Andrew O Anderson; Steven A Curley; Lon J Wilson; Stuart J Corr Journal: Nanomedicine (Lond) Date: 2018-12-03 Impact factor: 5.307
Authors: Xinqun Li; Mark A Truty; Ya'an Kang; Xavier Chopin-Laly; Ran Zhang; David Roife; Deyali Chatterjee; E Lin; Ryan M Thomas; Huamin Wang; Matthew H Katz; Jason B Fleming Journal: Clin Cancer Res Date: 2014-10-21 Impact factor: 12.531
Authors: Lauren E Colbert; Sarah B Fisher; Serdar Balci; Burcu Saka; Zhengjia Chen; Sungjin Kim; Bassel F El-Rayes; N Volkan Adsay; Shishir K Maithel; Jerome C Landry; Walter J Curran Journal: Int J Radiat Oncol Biol Phys Date: 2015-01-13 Impact factor: 7.038